KATHMANDU: NIBL Ace Capital Ltd has signed Roadmap for an IPO agreement under its corporate advisory service with National Biotech Pvt Ltd.
NIBL Ace Capital Deputy General Manager Sachindra Dhungana and National Biotech CEO Noorbindra Bikram Sijapati signed the agreement in presence of National Biotech Chairman Shyam Bikram Sijapati and Head of Corporate Advisory Service of NIBL Ace Capital, Bhuwan Raj Panta.
As per the agreement, NIBL Ace Capital will provide National Biotech with pre-IPO and IPO services.
In the first phase, NIBL Ace capital will provide consulting services in preparatory work to be done by the company before the issue of shares to the general public, on capital structure, issue process, size pricing and assist in necessary document preparation required in the process of conversion of private limited company into a public limited company as a part of corporate advisory.
Likewise, in the second phase, NIBL Ace Capital will work as the issue manager for the share to be issued to the general public.
NIBL Ace Capital, under its Corporate Advisory Services, has been providing services like business plans, market assessment & feasibility, equity raising, and raising & loan syndications to help develop business.
National Biotech is operating under Company’s Act, 2063 with its office registered in Kathmandu.
National Biotech is Nepal's first internationally certified organic company, producing high-quality organic fertiliser in granular form. It has more than 100 dealers and retailers across the country.
This company provides animal-based organic fertilisers, agriculture supplies, and animal and plant-based organic fertilisers to prestigious clients at very reasonable prices.
With the help of their experienced quality importers, exporters, and suppliers’ professionals, the company has been offering products in various ranges and models.
READ ALSO:
Published Date: March 28, 2023, 12:00 am
Post Comment
E-Magazine
Click Here To Read Full Issue
RELATED B360 National
